Cabergoline possesses a beneficial effect on blood-brain barrier (BBB) integrity against lipopolysaccharide (LPS)

References

• Czura CJ. “Merinoff symposium 2010: sepsis”-speaking with one voice. Mol Med. 2011;17:2–3.
   PubMed Web of Science ®Google Scholar
• Vincent JL, Opal SM, Marshall JC, et al. Sepsis definitions: time for change. Lancet. 2013;381:774–775.
   PubMed Web of Science ®Google Scholar
• Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013;41:580–637.
   PubMed Web of Science ®Google Scholar
• Molnar L, Fulesdi B, Nemeth N, et al. Sepsis-associated encephalopathy: a review of literature. Neurol India. 2018;66:352–361.
   PubMed Web of Science ®Google Scholar
• Zhang QH, Sheng ZY, Yao YM. Septic encephalopathy: when cytokines interact with acetylcholine in the brain. Mil Med Res. 2014;1:20.
   PubMedGoogle Scholar
• Zhang LN, Wang XT, Ai YH, et al. Epidemiological features and risk factors of sepsis-associated encephalopathy in intensive care unit patients: 2008-2011. Chin Med J (Engl). 2012;125:828–831.
   PubMed Web of Science ®Google Scholar
• Nishioku T, Dohgu S, Takata F, et al. Detachment of brain pericytes from the basal lamina is involved in disruption of the blood-brain barrier caused by lipopolysaccharide-induced sepsis in mice. Cell Mol Neurobiol. 2009;29:309–316.
   PubMed Web of Science ®Google Scholar
• Dal-Pizzol F, Tomasi CD, Ritter C. Septic encephalopathy: does inflammation drive the brain crazy? Braz J Psychiatry. 2014;36:251–258.
   PubMedGoogle Scholar
• Sankowski R, Mader S, Valdes-Ferrer SI. Systemic inflammation and the brain: novel roles of genetic, molecular, and environmental cues as drivers of neurodegeneration. Front Cell Neurosci. 2015;9:28.
   PubMed Web of Science ®Google Scholar
• Sharshar T, Mazeraud A, Verdonk F, et al. Brain perfusion in sepsis or to resolve the macro part of the micro. Crit Care Med. 2014;42:485–486.
   PubMed Web of Science ®Google Scholar
• Sharshar T, Annane D, de la Grandmaison GL, et al. The neuropathology of septic shock. Brain Pathol. 2004;14:21–33.
   PubMed Web of Science ®Google Scholar
• Alexander JJ, Jacob A, Cunningham P, et al. TNF is a key mediator of septic encephalopathy acting through its receptor, TNF receptor-1. Neurochem Int. 2008;52:447–456.
   PubMed Web of Science ®Google Scholar
• Xie J, Shen Z, Anraku Y, et al. Nanomaterial-based blood-brain-barrier (BBB) crossing strategies. Biomaterials. 2019;224:119491.
   PubMed Web of Science ®Google Scholar
• Huang Y, Chen S, Luo Y, et al. Crosstalk between Inflammation and the BBB in Stroke. Curr Neuropharmacol. 2020;18:1227–1236.
   PubMed Web of Science ®Google Scholar
• Gu M, Mei XL, Zhao YN. Sepsis and cerebral dysfunction: BBB damage, neuroinflammation, oxidative stress, apoptosis and autophagy as key mediators and the potential therapeutic approaches. Neurotox Res. 2021;39:489–503.
   PubMed Web of Science ®Google Scholar
• Davies DC. Blood-brain barrier breakdown in septic encephalopathy and brain tumours. J Anat. 2002;200:639–646.
   PubMed Web of Science ®Google Scholar
• Sharshar T, Carlier R, Bernard F, et al. Brain lesions in septic shock: a magnetic resonance imaging study. Intensive Care Med. 2007;33:798–806.
   PubMed Web of Science ®Google Scholar
• Greene C, Campbell M. Tight junction modulation of the blood brain barrier: CNS delivery of small molecules. Tissue Barriers. 2016;4:e1138017.
   PubMed Web of Science ®Google Scholar
• Townsend M, MacIver DH. Constrictive pericarditis and pleuropulmonary fibrosis secondary to cabergoline treatment for Parkinson’s disease. Heart. 2004;90:e47.
   PubMed Web of Science ®Google Scholar
• Chakroborty D, Sarkar C, Mitra RB, et al. Depleted dopamine in gastric cancer tissues: dopamine treatment retards growth of gastric cancer by inhibiting angiogenesis. Clin Cancer Res. 2004;10(13):4349–4356.
   PubMed Web of Science ®Google Scholar
• Novella-Maestre E, Carda C, Noguera I, et al. Dopamine agonist administration causes a reduction in endometrial implants through modulation of angiogenesis in experimentally induced endometriosis. Hum Reprod. 2009;24(5):1025–1035.
   PubMed Web of Science ®Google Scholar
• Zhang J, Ma L, Wan X, et al. (R)-Ketamine attenuates LPS-induced endotoxin-derived delirium through inhibition of neuroinflammation. Psychopharmacology (Berl). 2021;238(10):2743–2753.
   Web of Science ®Google Scholar
• Matsuo K, Sone M, Honda-Kohmo K, et al. Significance of dopamine D1 receptor signalling for steroidogenic differentiation of human induced pluripotent stem cells. Sci Rep. 2017;7(1):1512.
   PubMedGoogle Scholar
• Wei Y, Lu M, Mei M, et al. Pyridoxine induces glutathione synthesis via PKM2-mediated Nrf2 transactivation and confers neuroprotection. Nat Commun. 2020;11(1):941.
   PubMed Web of Science ®Google Scholar
• Zhong Y, Zhang B, Eum SY, et al. HIV-1 Tat triggers nuclear localization of ZO-1 via Rho signaling and cAMP response element-binding protein activation. J Neurosci. 2012;32:143–150.
   PubMed Web of Science ®Google Scholar
• Cheng Y, Desse S, Martinez A, et al. TNFalpha disrupts blood brain barrier integrity to maintain prolonged depressive-like behavior in mice. Brain Behav Immun. 2018;69:556–567.
   PubMed Web of Science ®Google Scholar
• Laksitorini MD, Yathindranath V, Xiong W, et al. Impact of Wnt/beta-catenin signaling on ethanol-induced changes in brain endothelial cell permeability. J Neurochem. 2021;157:1118–1137.
   PubMed Web of Science ®Google Scholar
• Pang Q, Hu W, Zhang X, et al. Wnt/beta-Catenin signaling pathway-related proteins (DK3, beta-Catenin, and c-MYC) are involved in prognosis of nasopharyngeal carcinoma. Cancer Biother Radiopharm. 2019;34:436–443.
   PubMed Web of Science ®Google Scholar
• Avtan SM, Kaya M, Orhan N, et al. The effects of hyperbaric oxygen therapy on blood-brain barrier permeability in septic rats. Brain Res. 2011;1412:63–72.
   PubMed Web of Science ®Google Scholar
• Banks WA, Gray AM, Erickson MA, et al. Lipopolysaccharide-induced blood-brain barrier disruption: roles of cyclooxygenase, oxidative stress, neuroinflammation, and elements of the neurovascular unit. J Neuroinflammation. 2015;12:223.
   PubMed Web of Science ®Google Scholar
• Kikuchi DS, Campos ACP, Qu H, et al. Poldip2 mediates blood-brain barrier disruption in a model of sepsis-associated encephalopathy. J Neuroinflammation. 2019;16:241.
   PubMed Web of Science ®Google Scholar
• Liu WY, Wang ZB, Zhang LC, et al. Tight junction in blood-brain barrier: an overview of structure, regulation, and regulator substances. CNS Neurosci Ther. 2012;18:609–615.
   PubMed Web of Science ®Google Scholar
• Wong D, Dorovini-Zis K, Vincent SR. Cytokines, nitric oxide, and cGMP modulate the permeability of an in vitro model of the human blood-brain barrier. Exp Neurol. 2004;190:446–455.
   PubMed Web of Science ®Google Scholar
• Honig G, Mader S, Chen H, et al. Blood-Brain barrier deterioration and hippocampal gene expression in polymicrobial sepsis: an evaluation of endothelial MyD88 and the vagus nerve. PLoS One. 2016;11:e0144215.
   PubMed Web of Science ®Google Scholar
• Cardoso FL, Kittel A, Veszelka S, et al. Exposure to lipopolysaccharide and/or unconjugated bilirubin impair the integrity and function of brain microvascular endothelial cells. PLoS One. 2012;7:e35919.
   PubMed Web of Science ®Google Scholar
• Yang CH, Kao MC, Shih PC, et al. Simvastatin attenuates sepsis-induced blood-brain barrier integrity loss. J Surg Res. 2015;194:591–598.
   PubMed Web of Science ®Google Scholar
• Haorah J, Heilman D, Knipe B, et al. Ethanol-induced activation of myosin light chain kinase leads to dysfunction of tight junctions and blood-brain barrier compromise. Alcohol Clin Exp Res. 2005;29:999–1009.
   PubMed Web of Science ®Google Scholar
• Han D, Fang W, Zhang R, et al. Clematichinenoside protects blood brain barrier against ischemic stroke superimposed on systemic inflammatory challenges through up-regulating A20. Brain Behav Immun. 2016;51:56–69.
   PubMed Web of Science ®Google Scholar
• Vedula SR, Lim TS, Kausalya PJ, et al. Biophysical approaches for studying the integrity and function of tight junctions. Mol Cell Biomech. 2005;2:105–123.
   PubMedGoogle Scholar
• Liebner S, Corada M, Bangsow T, et al. Wnt/beta-catenin signaling controls development of the blood-brain barrier. J Cell Biol. 2008;183:409–417.
   PubMed Web of Science ®Google Scholar
• Paolinelli R, Corada M, Ferrarini L, et al. Wnt activation of immortalized brain endothelial cells as a tool for generating a standardized model of the blood brain barrier in vitro. PLoS One. 2013;8:e70233.
   PubMed Web of Science ®Google Scholar
• Ramirez SH, Fan S, Dykstra H, et al. Inhibition of glycogen synthase kinase 3beta promotes tight junction stability in brain endothelial cells by half-life extension of occludin and claudin-5. PLoS One. 2013;8:e55972.
   PubMed Web of Science ®Google Scholar
• Shailesh H, Siveen KS, Sif S. Protein arginine methyltransferase 5 (PRMT5) activates WNT/beta-catenin signalling in breast cancer cells via epigenetic silencing of DKK1 and DKK3. J Cell Mol Med. 2021;25:1583–1600.
   PubMed Web of Science ®Google Scholar
• Xi M, Cheng L, Hua W, et al. MicroRNA-95-3p promoted the development of prostatic cancer via regulating DKK3 and activating Wnt/beta-catenin pathway. Eur Rev Med Pharmacol Sci. 2019;23:1002–1011.
   PubMed Web of Science ®Google Scholar
• Odaka H, Numakawa T, Adachi N, et al. Cabergoline, dopamine D2 receptor agonist, prevents neuronal cell death under oxidative stress via reducing excitotoxicity. PLoS One. 2014;9(6):e99271.
   PubMed Web of Science ®Google Scholar